MYD88 somatic mutations in MALT lymphomas

British Journal of Haematology

Volumn 158, Issue 5, 2012, Pages 662-664

  Li, Zhi Ming ^a,b   Rinaldi, Andrea ^a   Cavalli, Andrea ^c   Mensah, Afua A ^a   Ponzoni, Maurilio ^d   Gascoyne, Randy D ^e   Bhagat, Govind ^f   Zucca, Emanuele ^g   Bertoni, Francesco ^a,g  

^a INSTITUTE OF ONCOLOGY RESEARCH   (Switzerland)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

^f NewYork Presbyterian Hospital   (United States)

^g ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

MALT lymphoma; MYD88; New drugs for lymphoma; NF KB; Oncogenes

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; JANUS KINASE; MYELOID DIFFERENTIATION FACTOR 88; STAT3 PROTEIN;

AMINO ACID SUBSTITUTION; CHROMOSOMAL LOCALIZATION; DNA SEQUENCE; GENE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; HUMAN; INTERSTITIAL CHROMOSOME DELETION; LETTER; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MYD88 GENE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SOMATIC MUTATION; TRISOMY 13; TRISOMY 18; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; WALDENSTROEM MACROGLOBULINEMIA;

GENOME-WIDE ASSOCIATION STUDY; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MUTATION; MYELOID DIFFERENTIATION FACTOR 88; NEOPLASM RECURRENCE, LOCAL;

EID: 84865167399     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09176.x     Document Type: Letter

References (10)

1. Bertoni, F., Coiffier, B., Salles, G., Stathis, A., Traverse-Glehen, A., Thieblemont, C. & Zucca, E. (2011) MALT lymphomas: pathogenesis can drive treatment. Oncology (Williston Park), 25, 1134-1142, 1147.
2. Fabbri, G., Rasi, S., Rossi, D., Trifonov, V., Khiabanian, H., Ma, J., Grunn, A., Fangazio, M., Capello, D., Monti, S., Cresta, S., Gargiulo, E., Forconi, F., Guarini, A., Arcaini, L., Paulli, M., Laurenti, L., Larocca, L.M., Marasca, R., Gattei, V., Oscier, D., Bertoni, F., Mullighan, C.G., Foa, R., Pasqualucci, L., Rabadan, R., Dalla-Favera, R. & Gaidano, G. (2011) Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. Journal of Experimental Medicine, 208, 1389-1401.
3. Li, C., Zienkiewicz, J. & Hawiger, J. (2005) Interactive sites in the MyD88 Toll/Interleukin (IL) 1 receptor domain responsible for coupling to the IL1β signaling pathway. Journal of Biological Chemistry, 280, 26152-26159.
4. Mensah, A.A., Rinaldi, A., Ponzoni, M., Canzonieri, V., Uccella, S., Rossi, D., Bhagat, G., Gaidano, G., Zucca, E. & Bertoni, F. (2012) Absence of NOTCH1 gene mutations in MALT lymphomas. British Journal of Haematology, 157, 382-384.
5. Morin, R.D., Mendez-Lago, M., Mungall, A.J., Goya, R., Mungall, K.L., Corbett, R.D., Johnson, N.A., Severson, T.M., Chiu, R., Field, M., Jackman, S., Krzywinski, M., Scott, D.W., Trinh, D.L., Tamura-Wells, J., Li, S., Firme, M.R., Rogic, S., Griffith, M., Chan, S., Yakovenko, O., Meyer, I.M., Zhao, E.Y., Smailus, D., Moksa, M., Chittaranjan, S., Rimsza, L., Brooks-Wilson, A., Spinelli, J.J., Ben-Neriah, S., Meissner, B., Woolcock, B., Boyle, M., McDonald, H., Tam, A., Zhao, Y., Delaney, A., Zeng, T., Tse, K., Butterfield, Y., Birol, I., Holt, R., Schein, J., Horsman, D.E., Moore, R., Jones, S.J., Connors, J.M., Hirst, M., Gascoyne, R.D. & Marra, M.A. (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature, 476, 298-303.
6. Ngo, V.N., Young, R.M., Schmitz, R., Jhavar, S., Xiao, W., Lim, K.H., Kohlhammer, H., Xu, W., Yang, Y., Zhao, H., Shaffer, A.L., Romesser, P., Wright, G., Powell, J., Rosenwald, A., Muller-Hermelink, H.K., Ott, G., Gascoyne, R.D., Connors, J.M., Rimsza, L.M., Campo, E., Jaffe, E.S., Delabie, J., Smeland, E.B., Fisher, R.I., Braziel, R.M., Tubbs, R.R., Cook, J.R., Weisenburger, D.D., Chan, W.C. & Staudt, L.M. (2011) Oncogenically active MYD88 mutations in human lymphoma. Nature, 470, 115-119.
7. Rinaldi, A., Mian, M., Chigrinova, E., Arcaini, L., Bhagat, G., Novak, U., Rancoita, P.M., De Campos, C.P., Forconi, F., Gascoyne, R.D., Facchetti, F., Ponzoni, M., Govi, S., Ferreri, A.J., Mollejo, M., Piris, M.A., Baldini, L., Soulier, J., Thieblemont, C., Canzonieri, V., Gattei, V., Marasca, R., Franceschetti, S., Gaidano, G., Tucci, A., Uccella, S., Tibiletti, M.G., Dirnhofer, S., Tripodo, C., Doglioni, C., Dalla Favera, R., Cavalli, F., Zucca, E., Kwee, I. & Bertoni, F. (2011) Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood, 117, 1595-1604.
8. Wang, L., Lawrence, M.S., Wan, Y., Stojanov, P., Sougnez, C., Stevenson, K., Werner, L., Sivachenko, A., DeLuca, D.S., Zhang, L., Zhang, W., Vartanov, A.R., Fernandes, S.M., Goldstein, N.R., Folco, E.G., Cibulskis, K., Tesar, B., Sievers, Q.L., Shefler, E., Gabriel, S., Hacohen, N., Reed, R., Meyerson, M., Golub, T.R., Lander, E.S., Neuberg, D., Brown, J.R., Getz, G. & Wu, C.J. (2011) SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. New England Journal of Medicine, 365, 2497-2506.
9. Xu, L., Sohani, A.R., Arcaini, L., Hunter, Z., Yang, G., Zhou, Y., Liu, X., Cao, Y., Manning, R., Patterson, C.J., Ioakimidis, L., Tripsas, C., Pinkus, G.S., Harris, N.L., Rodig, S.J. & Treon, S. (2011) A somatic variant in MYD88 (L265P) revealed by whole genome sequencing differentiates lymphoplasmacytic lymphoma from marginal zone lymphomas. Blood (ASH Annual Meeting Abstracts), 118, 261.
10. Yan, Y., Huang, Y., Watkins, A.J., Kocialkowski, S., Zeng, N., Hamoudi, R.A., Isaacson, P.G., de Leval, L., Wotherspoon, A. & Du, M.Q. (2012) BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas. Haematologica, 97, 595-598.